Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality.
暂无分享,去创建一个
Angela Panoskaltsis-Mortari | D. Munn | A. Mellor | Lisa K. Jasperson | C. Bucher | B. Blazar | P. Taylor | Bruce R Blazar | Lisa K Jasperson | Christoph Bucher | Patricia A Taylor | Andrew L Mellor | David H Munn | A. Panoskaltsis‐Mortari
[1] B. Baban,et al. Cutting Edge: CpG Oligonucleotides Induce Splenic CD19+ Dendritic Cells to Acquire Potent Indoleamine 2,3-Dioxygenase-Dependent T Cell Regulatory Functions via IFN Type 1 Signaling1 , 2005, The Journal of Immunology.
[2] D. Beelen,et al. Indoleamine 2,3‐Dioxygenase Expression in Patients with Acute Graft‐versus‐Host Disease after Allogeneic Stem Cell Transplantation and in Pregnant Women: Association with the Induction of Allogeneic Immune Tolerance? , 2003, Scandinavian journal of immunology.
[3] T. Shima,et al. Expression of indoleamine 2, 3‐dioxygenase and the recruitment of Foxp3‐expressing regulatory T cells in the development and progression of uterine cervical cancer , 2007, Cancer science.
[4] C. Contag,et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. , 2005, Blood.
[5] D. Munn,et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.
[6] G. Visner,et al. Sleeping Beauty‐based gene therapy with indoleamine 2,3‐dioxygenase inhibits lung allograft fibrosis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] B. Baban,et al. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. , 2004, International immunology.
[8] K. Swanson,et al. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. , 2004, American journal of respiratory cell and molecular biology.
[9] Y. Koide,et al. The signal transduction mechanism responsible for gamma interferon-induced indoleamine 2,3-dioxygenase gene expression , 1994, Infection and immunity.
[10] M. V. D. van den Brink,et al. Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine. , 2006, Blood.
[11] G. Prendergast,et al. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy , 2005, Nature Medicine.
[12] T. George,et al. L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. , 2005, Blood.
[13] B. Baban,et al. Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion1 , 2003, The Journal of Immunology.
[14] D. Keskin,et al. Cells Expressing Indoleamine 2,3-Dioxygenase Inhibit T Cell Responses1 , 2002, The Journal of Immunology.
[15] B. Baban,et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. , 2005, Immunity.
[16] H. Nakano,et al. Transient upregulation of IDO in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes , 2007 .
[17] U. Grohmann,et al. T cell apoptosis by tryptophan catabolism , 2002, Cell Death and Differentiation.
[18] U. Grohmann,et al. The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells1 , 2006, The Journal of Immunology.
[19] E. Raz,et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. , 2004, The Journal of clinical investigation.
[20] D. Munn,et al. Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells1 , 2004, The Journal of Immunology.
[21] J. Serody,et al. In vivo imaging of graft-versus-host-disease in mice. , 2004, Blood.
[22] Jun Sik Lee,et al. Differential regulation of indoleamine 2,3‐dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells , 2007, FEBS letters.
[23] L. Tian,et al. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer. , 1998, Blood.
[24] B. Baban,et al. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. , 2004, Journal of reproductive immunology.
[25] H. Tilg,et al. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. , 2004, Clinical immunology.
[26] R. Newberry,et al. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. , 2003, Gastroenterology.
[27] H. Nakano,et al. Transient Upregulation of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Human Chorionic Gonadotropin Downregulates Autoimmune Diabetes , 2007, Diabetes.
[28] I. Bechmann,et al. Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] G. Trinchieri,et al. Murine Plasmacytoid Dendritic Cells Initiate the Immunosuppressive Pathway of Tryptophan Catabolism in Response to CD200 Receptor Engagement1 , 2004, The Journal of Immunology.